AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
Legence's 15min chart shows Bollinger Bands Narrowing and KDJ Death Cross.
ByAinvest
Thursday, Oct 2, 2025 2:36 pm ET1min read
According to the 15-minute chart provided by Legence, the Bollinger Bands are narrowing, and a KDJ Death Cross occurred on October 2, 2025 at 14:30. This suggests that the magnitude of stock price fluctuations is decreasing and that the momentum of the stock price is shifting towards the downside, with a potential for further decreases.
NeueHealth Inc. (NEUE), a technology-enabled healthcare solutions provider, has been making significant strides in the healthcare industry. The company's recent financial performance and market indicators provide valuable insights for investors and healthcare professionals.Financial Performance
NeueHealth reported strong financial results in the second quarter of 2025, marking its sixth consecutive quarter of Adjusted EBITDA profitability. The company served approximately 694,000 consumers, representing a 45% increase from the previous year . Key financial metrics for Q2 2025 include revenue of $209.1 million, net income from continuing operations of $6.8 million, and Adjusted EBITDA of $19.0 million .
The company's value-based consumers increased to 546,000, up from 364,000 in the previous year, while enablement services lives grew to 148,000 from 113,000 . NeueHealth continues to advance its end-to-end, value-based care enablement platform across ACA Marketplace, Medicare, and Medicaid product categories .
Market Indicators
According to the 15-minute chart provided by Legence, the Bollinger Bands are narrowing, and a KDJ Death Cross occurred on October 2, 2025, at 14:30. This suggests that the magnitude of stock price fluctuations is decreasing and that the momentum of the stock price is shifting towards the downside, with a potential for further decreases .
Recent Developments
NeueHealth has completed its previously announced take-private merger with New Enterprise Associates (NEA) in a transaction valued at approximately $1.465 billion. Common stockholders will receive $7.33 per share in cash, while certain stockholders, including NEA and 12 existing investors, have opted to roll over their shares into the private entity [1]. Following the transaction, NeueHealth's common stock ceased trading on the NYSE on October 2, 2025, and the company will terminate its SEC reporting obligations [1].
Conclusion
NeueHealth's recent financial performance and market indicators provide a mixed picture for investors. While the company continues to show strong financial results, the narrowing Bollinger Bands and KDJ Death Cross suggest a potential downward trend in the stock price. Investors should closely monitor these indicators and the company's future earnings reports to make informed investment decisions.
References
[1] https://www.stocktitan.net/news/NEUE/
https://www.stocktitan.net/news/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NEUE/NE
Ainvest News articles are AI-generated using advanced large language model (LLM) technology designed to analyze and synthesize publicly available data and news. While AI tools assist in producing initial drafts and insights, all AI generated content published on Ainvest is subject to comprehensive human editorial review before publication. A designated human editor reviews, verifies, and approves each article for factual accuracy, coherence, and compliance with AInvest Fintech Incβs editorial and disclosure standards.
Despite these review procedures, the information provided may still contain inaccuracies, incomplete data, or time sensitive references due to the inherent limitations of AI generated analysis and evolving changes. The material is provided strictly for informational and educational purposes and does not constitute personalized investment, legal, or financial advice. Readers should independently verify all facts, figures, and statements before making any decision based on this content.
AInvest Fintech Inc. its affiliates, and partners accept no liability or responsibility for any direct or consequential losses arising from reliance on this content. All articles and analyses are subject to revision, update, or removal without prior notice to maintain accuracy and integrity in our publications.
Comments
ο»Ώ
No comments yet